Patents by Inventor David W. Houze

David W. Houze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
    Publication number: 20140243764
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Application
    Filed: February 27, 2014
    Publication date: August 28, 2014
    Applicant: Noven Pharmaceuticals, Inc.
    Inventors: David Kanios, Rod Hartwig, Juan Mantelle, David W. Houze
  • Transdermal levonorgestrel device and delivery
    Patent number: 8784877
    Abstract: Described are transdermal drug delivery systems for the transdermal administration of levonorgestrel, comprising a polymer matrix and levonorgestrel acetate. Methods of making and using such systems also are described.
    Type: Grant
    Filed: December 27, 2011
    Date of Patent: July 22, 2014
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: David W. Houze, Vincent Lau Chan
  • Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
    Patent number: 8703175
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: April 22, 2014
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: David P. Kanios, Rod Hartwig, Juan A. Mantelle, David W. Houze
  • TRANSDERMAL LEVONORGESTREL DEVICE AND DELIVERY
    Publication number: 20120189686
    Abstract: Described are transdermal drug delivery systems for the transdermal administration of levonorgestrel, comprising a polymer matrix and levonorgestrel acetate. Methods of making and using such systems also are described.
    Type: Application
    Filed: December 27, 2011
    Publication date: July 26, 2012
    Inventors: David W. Houze, Vincent Lau Chan
  • COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
    Publication number: 20100310610
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 9, 2010
    Inventors: David P. Kanios, Rod Hartwig, Juan A. Mantelle, David W. Houze